Online Database of Chemicals from Around the World

Dipotassium glycyrrhizinate
[CAS# 68797-35-3]

List of Suppliers
Spec-Chem Industry Inc. China Inquire  
+86 (25) 8452-3390 ex 111
sc@specchemind.com
Chemical manufacturer since 1995
chemBlink standard supplier since 2006
Richchem International Trading Co., Ltd. China Inquire  
+86 (411) 8278-9167
8278-9168
8278-9169
xie_ruiqiang@chemrg.com
Chemical manufacturer since 2003
chemBlink standard supplier since 2006
Fraken Biochem Co., Ltd. China Inquire  
+86 (532) 8389-9718
fraken@fraken.cn
Chemical manufacturer
chemBlink standard supplier since 2006
Fanzhi Pharmacy Co., Ltd. China Inquire  
+86 (931) 855-9501
855-9502
glycyrrhiza@fanzhigroup.com
Chemical manufacturer since 1995
chemBlink standard supplier since 2007
Simagchem Corporation China Inquire  
+86 13806087780
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2008
Shanghai Healthwell Chemical Co., Ltd. China Inquire  
+86 (21) 3424-0001
info@healthwell.cn
Chemical distributor
chemBlink standard supplier since 2008
Abend Trading & Consulting Germany Inquire  
+49 (421) 396-2896
abendtrading@aol.com
Chemical manufacturer
chemBlink standard supplier since 2009
Hefei TNJ Chemical Industry Co., Ltd. China Inquire  
+86 (551) 6541-8684
sales@tnjchem.com
Chemical manufacturer since 2001
chemBlink standard supplier since 2010
Complete supplier list of Dipotassium glycyrrhizinate
Identification
Classification Biochemical >> Carbohydrate >> Double sugar
Name Dipotassium glycyrrhizinate
Synonyms Dipotassium (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate
Molecular Structure CAS # 68797-35-3, Dipotassium glycyrrhizinate, Dipotassium (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate
Molecular Formula C42H60K2O16
Molecular Weight 899.12
CAS Registry Number 68797-35-3
EC Number 272-296-1
SMILES C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)[O-])O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)[O-])O)O)O)C)(C)C(=O)O.[K+].[K+]
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H302-H315-H319-H335    Details
Precautionary Statements P261-P305+P351+P338    Details
SDS Available
up Discovory and Applicatios
Dipotassium glycyrrhizinate is a salt derivative of glycyrrhizic acid, a triterpenoid saponin primarily extracted from the roots of Glycyrrhiza species, commonly known as licorice. Chemically, it consists of glycyrrhizic acid neutralized with two potassium ions, which increases its water solubility and stability compared to the free acid form. This compound has been widely studied for its anti-inflammatory, antioxidant, hepatoprotective, and skin-soothing properties, making it a valuable ingredient in pharmaceutical, nutraceutical, and cosmetic applications.

The discovery of glycyrrhizic acid dates back to the early 20th century when researchers investigated the active constituents responsible for the sweet taste and therapeutic properties of licorice roots. Dipotassium glycyrrhizinate was subsequently developed to improve the solubility and handling of glycyrrhizic acid for practical applications. Structural characterization was achieved through chromatographic separation and spectroscopic techniques, facilitating research into its pharmacological effects and therapeutic mechanisms.

Pharmacologically, dipotassium glycyrrhizinate exhibits potent anti-inflammatory activity. It can inhibit the production of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukins, and suppress enzymes involved in inflammation, including cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). These effects are mediated through the modulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathways, providing potential therapeutic applications in inflammatory disorders and skin conditions such as dermatitis and eczema.

Dipotassium glycyrrhizinate also demonstrates significant antioxidant activity. Its triterpenoid structure allows it to scavenge reactive oxygen species (ROS) and reduce oxidative stress in tissues, contributing to its protective effects in liver cells and other organs. This antioxidant activity underpins its hepatoprotective potential, where it can mitigate liver damage caused by toxins, viral infections, or metabolic stress.

In addition to anti-inflammatory and antioxidant properties, dipotassium glycyrrhizinate has demonstrated skin-soothing and anti-allergic effects. It stabilizes mast cells, inhibits histamine release, and reduces skin irritation and erythema, which has led to its widespread use in cosmetic and dermatological formulations. Its ability to reduce oxidative stress and inflammatory responses in the skin makes it a valuable active ingredient in creams, lotions, and serums designed to treat sensitive or inflamed skin.

The compound has also been investigated for antiviral activity, particularly against hepatitis viruses, where it can modulate immune responses and reduce viral replication in vitro. These properties suggest potential applications in supportive therapies for viral infections, although clinical use requires further investigation.

Dipotassium glycyrrhizinate is generally well tolerated, with low toxicity and a favorable safety profile observed in preclinical and clinical studies. Its enhanced water solubility compared to glycyrrhizic acid allows for easier formulation in oral, topical, and cosmetic products, improving its practical applications.

Overall, dipotassium glycyrrhizinate is a bioactive triterpenoid salt with anti-inflammatory, antioxidant, hepatoprotective, skin-soothing, and potential antiviral activities. Its development from glycyrrhizic acid and subsequent research highlight its therapeutic versatility in both pharmaceutical and cosmetic contexts.

References

2013. Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model. Indian journal of experimental biology.
URL: https://pubmed.ncbi.nlm.nih.gov/23923606

2012. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiology of Disease.
DOI: 10.1016/j.nbd.2011.12.056

2025. Glycyrrhizin and its derivatives: an emerging secondary metabolite arsenal of Glycyrrhiza glabra. Medicinal Chemistry Research.
DOI: 10.1007/s00044-025-03376-7
Market Analysis Reports
List of Reports Available for Dipotassium glycyrrhizinate
Related Products
Dipiperidinomethane  2,16-Dipiperidin-1-ylandrosta-3,17-diol  Di-O,O'-pivaloyl-D-tartaric acid  L-Dipivaloyltartaric acid  Dipivefrine  Dipivefrin hydrochloride  Dipotassium 5-amino-4-hydroxybenzene-1,3-disulphonate  Dipotassium bis(p-sulfonatophenyl)phenylphosphine dihydrate  Dipotassium cupric ethylenediaminetetraacetate  Dipotassium dioxalatoplatinate hydrate  Dipotassium D-glucose-6-phosphate  Dipotassium hexachloroiridate  Dipotassium hexachloroosmate  Dipotassium hexachloropalladate  Dipotassium hydrogenphosphate  Dipotassium hydrogen phosphate trihydrate  Dipotassium 7-hydroxynaphthalene-1,3-disulphonate  Dipotassium 2-hydroxy-5-nitrophenyl sulfate  Dipotassium methanedisulfonate